Long-term use of acid suppression started inappropriately during hospitalization

Alimentary Pharmacology and Therapeutics

Volumn 21, Issue 10, 2005, Pages 1203-1209

  Zink, D A ^a   Pohlman, M ^a,b   Barnes, M ^a   Cannon, M E ^a  

^a WILLIAM BEAUMONT HOSPITAL   (United States)

^b UNIVERSITY OF CHICAGO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTACID AGENT; HEPARIN; HISTAMINE H2 RECEPTOR ANTAGONIST; NONSTEROID ANTIINFLAMMATORY AGENT; PROTON PUMP INHIBITOR; STEROID; WARFARIN;

ADULT; AGED; ARTICLE; DRUG USE; HOSPITAL DISCHARGE; HOSPITAL PATIENT; HOSPITALIZATION; HUMAN; LENGTH OF STAY; LONG TERM CARE; MAJOR CLINICAL STUDY; MEDICAL RECORD; MULTIVARIATE ANALYSIS; PREDICTION; PRESCRIPTION; PRIORITY JOURNAL; RETROSPECTIVE STUDY; STOMACH ACID SECRETION; TREATMENT INDICATION; TREATMENT OUTCOME;

AGED; ANTACIDS; DRUG ADMINISTRATION SCHEDULE; DRUG UTILIZATION REVIEW; FOLLOW-UP STUDIES; HEALTH SERVICES MISUSE; HOSPITALS, TEACHING; HUMANS; LENGTH OF STAY; MICHIGAN; MIDDLE AGED; PATIENT DISCHARGE; PRESCRIPTIONS, DRUG; RETROSPECTIVE STUDIES; SELF ADMINISTRATION;

EID: 19544382548     PISSN: 02692813     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-2036.2005.02454.x     Document Type: Article

References (28)

1. American Society of Health-System Pharmacists. ASHP Therapeutic Guidelines on stress ulcer prophylaxis. Am J Health Syst Pharm 1999; 56: 347-79.
2. Lanza FL. A guideline for the treatment and prevention of NSAID-induced ulcers. Am J Gastroenterol 1998; 93: 2037-46.
3. Ryder SD, O'Reilly S, Miller RJ, et al. Long term acid suppressing treatment in general practice. Br Med J 1994; 308: 827-30.
4. Wadibia EC, Lucas BD, Hilleman DE, et al. Economic impact of inappropriate histamine-2 receptor antagonist use. Clin Ther 1997; 19: 1085-91.
5. Gullotta R, Ferraris L, Cortelezzi C, et al. Are we correctly using the inhibitors of gastric acid secretion and cytoprotective drugs? Results of a multicentre study. Ital J Gastroenterol Hepatol 1997; 29: 325-9.
6. Nardino RJ, Vender RJ, Herbert PN. Overuse of acid-suppressive therapy in hospitalized patients. Am J Gastroenterol 2000; 95: 3118-22.
7. Cook DJ, Fuller HD, Guyatt GH, et al. Risk factors for gastrointestinal bleeding in critically ill patients. N Engl J Med 1994; 330: 377-81.
8. Zinner MJ, Zuidema GD, Smith PL, et al. The prevention of upper gastrointestinal tract bleeding in patients in an intensive care unit. Surg Gynecol Obstet 1981; 153: 214-20.
9. Tryba M, Huchzermeyer H, Torok M, et al. Single-drug and combined medication with cimetidine, antacids and pirenzepine in the prophylaxis of acute upper gastrointestinal bleeding. Hepatogastroenterology 1983; 30: 154-7.
10. Silen W. The clinical problem of stress ulcers. Clin Invest Med 1987; 10: 270-4.
11. Le Gall JR, Mignon FC, Rapin M, et al. Acute gastroduodenal lesions related to severe sepsis. Surg Gynecol Obstet 1976; 142: 377-80.
12. Shuman RB, Schuster DP, Zuckerman GR. Prophylactic therapy for stress ulcer bleeding: a reappraisal. Ann Intern Med 1987; 106: 562-7.
13. Meshkinpour H, Molinari MD, Gardner L. Cimetidine in the treatment of acute alcoholic pancreatitis. A randomized, double-blind study. Gastroenterology 1979; 77: 687-90.
14. Goff JS, Feinberg LE, Brugge WR. A Rondomized trial comparing cimetidine to nasogastric suction in acute pancreatitis. Dig Dis Sci 1982; 27: 1085-8.
15. Broe PJ, Zinner MJ, Cameron JL. A clinical trial of cimetidine in acute pancreatitis. Surg Gynecol Obstet 1982; 154: 13-6.
16. Conn HO, Poynard T. Corticosteroids and peptic ulcer: meta-analysis of adverse events during steroid therapy. J Intern Med 1994; 236: 619-32.
17. Piper JM, Ray W, Daugherty JR. Corticosteroid use and peptic ulcer disease: role of nonsteroidal anti-inflammatory drugs. Ann Intern Med 1991; 114: 735-40.
18. Gabriel SE, Jaakkimainen L, Bombardier C. Risk for serious gastrointestinal complications related to use of nonsteroidal anti-inflammatory drugs. A meta-analysis. Ann Intern Med 1991; 115: 787-96.
19. Griffin MR, Piper JM, Daugherty JR, et al. Nonsteroidal anti-inflammatory drug use and increased risk for peptic ulcer disease in elderly person. Ann Intern Med 1991; 114: 257-63.
20. Sharr RJ, Ray WA, Daugherty JR, et al. Concurrent use of nonsteroidal anti-inflammatory drugs and oral anticoagulants places elderly persons at high risk for hemorrhagic peptic ulcer disease. Arch Intern Med 1993; 153: 1665-70.
21. Weil J, Colin-Jones D, Langman M, et al. Prophylactic aspirin and risk of peptic ulcer bleeding. Br Med J 1995; 310: 827-30.
22. Freston JW. Omeprazole, hypergastrinemia, and gastric carcinoid tumors. Ann Intern Med 1994; 121: 232.
23. Marcuard SP, Albernaz L, Khazanie PG. Omeprazole therapy causes malabsorption of cyanocobalamin (vitamin B12). Ann Intern Med 1994; 120: 211-5.
24. Cunningham R, Dale B, Undy B, Gaunt N. Proton pump inhibitors as a risk for Clostridium difficile diarrhoea. J Hosp Infect 2003; 54: 243-5.
25. Neal NR, Scott HM, Slack RC, Logan RF. Omeprazole as a risk factor for Campylobacter gastroenteritis: case-control study. BMJ 1996; 312:414.
26. Laheij RJF, Sturkenboom MCJM, Massing R-J, et al. Risk of community-acquired pneumonia and use of gastric acid-suppressive drugs. JAMA 2004; 294: 1955-60.
27. The Nation's Health Dollar: 2003. Centers for Medicare and Medicaid Services. 5 April 2005. 〈http://www.cms.hhs.gov/statistics/nhe/historical/ chart.asp〉.
28. Hoffman JM, Shah ND, Vermeulen LC, Hunkler RJ, Hontz KM. Projecting future drug expenditures - 2004. Am J Health Syst Pharm 2004; 61: 145-58.